Significant clinical & MRI improvements shown with PLEGRIDY

A board to discuss the Multiple Sclerosis modifying drug Plegridy
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Significant clinical & MRI improvements shown with PLEGRIDY

Post by MSUK » Tue Oct 01, 2013 1:10 am

Significant clinical and MRI improvements shown with PLEGRIDY(TM) (Peginterferon Beta-1a)

Biogen Idec announced new data analyses from year one of the two-year, pivotal, Phase 3 ADVANCE study of PLEGRIDY(TM) (peginterferon beta-1a). PLEGRIDY is an investigational subcutaneous injectable for relapsing forms of multiple sclerosis (RMS), in which interferon beta-1a is pegylated to prolong the molecule's exposure in the body and enable the study of a less frequent dosing schedule. Clinical and MRI data from the study demonstrated a reduction in relapses, disability progression and the number of MS lesions when compared to placebo, and further support the clinical efficacy profile of PLEGRIDY. These data will be presented this week at the 29(th) Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark 2-5 October....... Read More - http://www.ms-uk.org/PEGylatedinterferonbeta
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post